SG Americas Securities’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-50,900
| Closed | -$2.62M | – | 3709 |
|
|
2025
Q4 | $2.62M | Buy |
50,900
+43,400
| +579% | +$24.5M | ﹤0.01% | 1382 |
|
|
2025
Q3 | $1.02M | Buy |
7,500
+2,600
| +53% | +$1.21M | ﹤0.01% | 1439 |
|
|
2025
Q2 | $644K | Buy |
+4,900
| New | +$2.05M | ﹤0.01% | 1475 |
|
|
2024
Q4 | – | Sell |
-25,300
| Closed | -$561K | – | 3619 |
|
|
2024
Q3 | $561K | Buy |
25,300
+20,000
| +377% | +$11.8M | ﹤0.01% | 1584 |
|
|
2024
Q2 | $187K | Sell |
5,300
-49,200
| -90% | -$28.2M | ﹤0.01% | 2206 |
|
|
2024
Q1 | $377K | Buy |
+54,500
| New | +$30.6M | ﹤0.01% | 1559 |
|
|
2023
Q3 | – | Sell |
-16,500
| Closed | -$178K | – | 3264 |
|
|
2023
Q2 | $178K | Sell |
16,500
-7,800
| -32% | -$4.21M | ﹤0.01% | 1845 |
|
|
2023
Q1 | $738K | Sell |
24,300
-13,400
| -36% | -$7.55M | 0.01% | 1399 |
|
|
2022
Q4 | $801K | Buy |
37,700
+23,500
| +165% | +$12.5M | 0.01% | 1129 |
|
|
2022
Q3 | $187K | Buy |
14,200
+1,800
| +15% | +$1.01M | ﹤0.01% | 2385 |
|
|
2022
Q2 | $378K | Sell |
12,400
-10,800
| -47% | -$5.94M | ﹤0.01% | 2197 |
|
|
2022
Q1 | $1.21M | Sell |
23,200
-8,300
| -26% | -$4.77M | 0.01% | 1283 |
|
|
2021
Q4 | $3.05M | Sell |
31,500
-1,000
| -3% | -$624K | 0.02% | 768 |
|
|
2021
Q3 | $1.33M | Buy |
32,500
+19,000
| +141% | +$10.4M | 0.01% | 1664 |
|
|
2021
Q2 | $427K | Buy |
13,500
+7,500
| +125% | +$3.54M | ﹤0.01% | 2010 |
|
|
2021
Q1 | $105K | Sell |
6,000
-32,500
| -84% | -$15.5M | ﹤0.01% | 3061 |
|
|
2020
Q4 | $3.64M | Buy |
38,500
+18,500
| +93% | +$8.67M | 0.02% | 697 |
|
|
2020
Q3 | $2.23M | Hold |
20,000
| – | – | 0.01% | 685 |
|
|
2020
Q2 | $962K | Hold |
20,000
| – | – | 0.01% | 1450 |
|
|
2020
Q1 | $218K | Sell |
20,000
-107,600
| -84% | -$33.9M | ﹤0.01% | 2446 |
|
|
2019
Q4 | $1.33M | Buy |
+127,600
| New | +$38.7M | 0.01% | 1076 |
|
|
2018
Q4 | – | Sell |
-2,700
| Closed | -$138K | – | 3328 |
|
|
2018
Q3 | $138K | Buy |
+2,700
| New | +$621K | ﹤0.01% | 2730 |
|
|
2018
Q1 | – | Sell |
-16,600
| Closed | -$361K | – | 3546 |
|
|
2017
Q4 | $361K | Hold |
16,600
| – | – | ﹤0.01% | 2056 |
|
|
2017
Q3 | $361K | Buy |
16,600
+2,700
| +19% | +$489K | ﹤0.01% | 2084 |
|
|
2017
Q2 | $221K | Hold |
13,900
| – | – | ﹤0.01% | 2350 |
|
|
2017
Q1 | $96K | Sell |
13,900
-36,300
| -72% | -$5.55M | ﹤0.01% | 3006 |
|
|
2016
Q4 | $80K | Buy |
50,200
+13,900
| +38% | +$2.05M | ﹤0.01% | 2901 |
|
|
2016
Q3 | $142K | Hold |
36,300
| – | – | ﹤0.01% | 2784 |
|
|
2016
Q2 | $97K | Buy |
+36,300
| New | +$5.36M | ﹤0.01% | 2396 |
|
Other funds holding TMO
VCM
SG Americas Securities's TMO Position: Q1 2026 in Review
SG Americas Securities increased its Thermo Fisher Scientific (TMO) stake by 7.6% in Q1 2026, buying an estimated $5.54M and bringing the position to 143,935 shares worth $66.7M. The position accounts for 0.07% of the portfolio, ranked #225.
SG Americas Securities first reported a position in TMO in Q2 2013 and has held it in 51 quarters since. The position peaked at $237M in Q2 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- SG Americas Securities held 143,935 shares of Thermo Fisher Scientific worth $66.7M as of Q1 2026.
- SG Americas Securities bought 10,210 Thermo Fisher Scientific shares in Q1 2026, an estimated $5.54M.
- Thermo Fisher Scientific made up 0.07% of SG Americas Securities's portfolio in Q1 2026, its #225 holding.
- SG Americas Securities first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 51 quarters since.
- SG Americas Securities's Thermo Fisher Scientific position peaked at $237M in Q2 2021.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.